Option Care CFO receives 27,045-share equity grant

Sethna Meenal reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/19/2026 - 07:25 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Sethna Meenal reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health, Inc. Chief Financial Officer Meenal Sethna reported an equity award of 27,045 shares of common stock, received as a grant with no cash price per share. These restricted stock units vest in three equal annual installments, and her directly held common stock increased to 82,112 shares after the award.

Insider Trade Summary

Grant/Award: 27,045 shares

Grant/Award 1 txn

Insider Sethna Meenal

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	27,045	$0.00	$0.00

Holdings After Transaction: Common Stock — 82,112 shares (Direct)

Footnotes (1)

1. F1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Option Care Health (OPCH) report for CFO Meenal Sethna?

Option Care Health reported that CFO Meenal Sethna acquired 27,045 shares of common stock through an equity award. The transaction was coded as a grant or award acquisition, not an open-market purchase, and was reported as a direct ownership position.

How many Option Care Health (OPCH) shares were granted to the CFO in this Form 4?

The CFO received 27,045 shares of Option Care Health common stock in this reported transaction. The filing classifies the event as a grant or award acquisition, with no cash price per share indicated for the newly awarded shares.

What is the vesting schedule for the Option Care Health (OPCH) restricted stock units granted to the CFO?

The restricted stock units granted to the CFO vest over three years. One third of the underlying common shares vests on each of the first, second, and third anniversaries of the grant date, according to the footnote in the Form 4 filing.

How many Option Care Health (OPCH) shares does the CFO own after this equity award?

After the reported grant, the CFO directly holds 82,112 shares of Option Care Health common stock. This total reflects the addition of 27,045 granted shares, as disclosed in the Form 4, and is reported as a direct ownership position.

Was the Option Care Health (OPCH) CFO’s Form 4 transaction a purchase or a stock grant?

The transaction was a stock grant, not an open-market purchase. It is coded as a grant, award, or other acquisition, with a reported price per share of 0.0000, indicating an equity-based compensation award rather than a cash-funded share purchase.

What type of security was involved in the Option Care Health (OPCH) CFO’s Form 4 transaction?

The filing shows the transaction involved common stock of Option Care Health. The shares arise from restricted stock units that convert into common shares as they vest over three annual installments following the original grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sethna Meenal

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		27,045(1)	A	$0	82,112	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro, attorney-in-fact for Ms. Sethna	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.